Abstract 2771: Harnessing novel immune escape mechanisms for cancer therapeutics: OXAB1 target validation, proof of concept and preclinical development
Deban, Livija, Cao, Wei, Fu, Yaoyao, Kaplan, Angelo, Duesk, Rachel L., Bisht, Arnima, Swaminathan, Sudha, Lou, San Lin, Amoury, Manal, Adelegan, Bukky, Berry, Joanne, Ackroyd, James E., Hannum, Chuck, Boyd, Robert, Rohlff, Christian, Huang, Haining
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Harnessing novel immune escape mechanisms for cancer therapeutics: OXAB1 target validation, proof of concept and preclinical development
Deban, Livija, Cao, Wei, Fu, Yaoyao, Kaplan, Angelo, Dusek, Rachel, Bisht, Arnima, Swaminathan, Sudha, Lou, San Lin, Amoury, Manal, Adelegan, Bukky, Berry, Joanne, Ackroyd, Jim, Hanum, Chuck, Boyd, Robert, Rohlff, Christian, Huang, Haining
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article